The Indian Journal of Pediatrics

, Volume 75, Issue 5, pp 521–522

Infliximab treatment in refractory Kawasaki syndrome

Clinical Brief

DOI: 10.1007/s12098-008-0084-8

Cite this article as:
Girish, M. & Subramaniam, G. Indian J Pediatr (2008) 75: 521. doi:10.1007/s12098-008-0084-8

Abstract

Kawasaki syndrome is one of the commonest vasculitides in pediatric age group with devastating consequences if not treated early. Intravenous Gammaglobulin leads to rapid amelioration of clinical symptoms and significantly decreases the risk of development of coronary artery aneurysms. Occasionally, Kawasaki disease may be resistant to I/V IgG. We present our experience with one such patient who ultimately respondend to infliximab therapy.

Key words

Coronary artery aneurysm Intravenous Gammaglobulin Infliximab Resistant Kawasaki syndrome 

Copyright information

© Dr. K C Chaudhuri Foundation 2008

Authors and Affiliations

  1. 1.Children’s Hospital, Midas HeightsNagpurIndia
  2. 2.MD, DNB, 101, Shubham Enclave, Darda Marg, Rahate ColonyNagpurIndia

Personalised recommendations